SCHEMBL6498382

SCHEMBL6498382

CCc1ccc(-c2cccc(-n3cc(NC(N)=O)c(C(N)=O)n3)c2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITK Q08881 1/20 0.45
IKBKB O14920 1/20 0.42
SCN9A Q15858 1/20 0.42
SMN1; SMN2 Q16637 6/20 0.41
KDM4E B2RXH2 5/20 0.41
ALDH1A1 P00352 4/20 0.41
NPC1 O15118 4/20 0.41
MAPT P10636 3/20 0.41
RAB9A P51151 3/20 0.41
MAPK1 P28482 2/20 0.41
TP53 P04637 1/20 0.41
ALOX15 P16050 1/20 0.41
HSD17B10 Q99714 1/20 0.41
HTT P42858 4/20 0.40
IRAK4 Q9NWZ3 2/20 0.40
PARP1 P09874 1/20 0.40
LMNA P02545 4/20 0.40
GAA P10253 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
HIF1A Q16665 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6467910 0.91 ITK (0.44) ITKSCN9ASMN1; SMN2KDM4EALDH1A1
SCHEMBL6468754 0.90 ITK (0.43) ITKSCN9ASMN1; SMN2KDM4EALDH1A1
SCHEMBL6498196 0.90 ITK (0.42) ITKSCN9ASMN1; SMN2ALDH1A1MAPT
SCHEMBL6508447 0.89 ITK (0.47) ITKSCN9ASMN1; SMN2KDM4EALDH1A1
SCHEMBL6501255 0.87 ITK (0.45) ITKIKBKBSCN9ASMN1; SMN2KDM4E
SCHEMBL6499548 0.87 ITK (0.45) ITKIKBKBSCN9ASMN1; SMN2KDM4E
SCHEMBL6470279 0.87 SCN9A (0.42) ITKSCN9ASMN1; SMN2KDM4EALDH1A1
SCHEMBL6506609 0.87 ITK (0.49) ITKSCN9ASMN1; SMN2KDM4EALDH1A1
SCHEMBL6504845 0.86 ITK (0.46) ITKSCN9ASMN1; SMN2KDM4EALDH1A1
SCHEMBL6470665 0.86 ITK (0.46) ITKSCN9ASMN1; SMN2KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050197338-A1 Substituted pyrazole urea compounds for the treatment of inflammation PHARMACIA AND UPJOHN COMPANY LLC 2005-09-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050197338-A1 Substituted pyrazole urea compounds for the treatment of inflammation IL4, ARG2, CASP4 ITK 4236/4885IKBKB 664/4885SCN9A 4159/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.